# Reprogramming T Cells to Cross the Brain’s Border Page: https://stenobird.com/podcast/the-bio-report-1092382/reprogramming-t-cells-to-cross-the-brain-s-border Text version: https://stenobird.com/podcast/the-bio-report-1092382/reprogramming-t-cells-to-cross-the-brain-s-border.md Podcast: [The Bio Report](https://stenobird.com/podcast/the-bio-report-1092382) Published: 2026-02-04T08:00:00+00:00 Episode link: https://thebioreport.podbean.com/e/reprogramming-t-cells-to-cross-the-brain-s-border/ Audio file: https://mcdn.podbean.com/mf/web/fvvwqijjvj657deu/BR-Michael_Roberts_-_2-4-26b4qpw.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/reprogramming-t-cells-to-cross-the-brain-s-border Duration seconds: 2327 ## Resource One of the challenges of treating brain tumors is delivering potent biologic therapies across the blood-brain barrier. Adaptin Bio has developed platform technology that harnesses a patient’s own T cells to transport bispecific therapeutic payloads across the blood-brain barrier and into other targeted tissue with an initial focus on treating glioblastoma. We spoke to Michael Roberts, co-founder and CEO of Adaptin Bio, about the unmet need in glioblastoma, the limitations of current blood-brain barrier–crossing strategies, and how the company’s platform seeks to change the treatment paradigm by using patient-derived T cells as delivery vehicles for targeted biologics. ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-bio-report-1092382/episodes/reprogramming-t-cells-to-cross-the-brain-s-border/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/the-bio-report-1092382/reprogramming-t-cells-to-cross-the-brain-s-border.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.